We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Udg Healthcare Public Limited Company | LSE:UDG | London | Ordinary Share | IE0033024807 | ORD EUR0.05 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,079.00 | 1,078.00 | 1,079.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/11/2018 17:10 | Good volume day. | tsmith2 | |
28/11/2018 16:00 | Triple bottom at 620... | tsmith2 | |
28/11/2018 15:34 | Nice support forming at 620 | tsmith2 | |
28/11/2018 15:14 | re-cap from yesterday: Peel Hunt reiterates buy rating and 1,105p target price. Liberium Capital reiterates buy rating and 884 target price. GLA. | mfhmfh | |
28/11/2018 14:22 | fading fast now | hyper ai | |
28/11/2018 14:17 | Re-cap from yesterday: Third quarter trading update stated: 'The Group reiterates its full year guidance for constant currency adjusted diluted earnings per share (EPS) growth for the year to 30 September 2018 to be between 18% and 21% ahead of last year's EPS of 37.1 $ cent'. Today's preliminary results: 'Solid performance drives 22% full-year constant currency EPS growth'. results beat estimates. | mfhmfh | |
28/11/2018 14:06 | hopefully the seller has cleared. | mfhmfh | |
28/11/2018 13:59 | and 39k at 632.25 | tsmith2 | |
28/11/2018 12:56 | What odds the 25k at 6.30 is a director but..? | tsmith2 | |
28/11/2018 12:45 | £6.5 on good volume = gap up to £7 | tsmith2 | |
28/11/2018 11:49 | summary from yesterday's IC: 'Cash conversion was a slight concern, reaching just 39 per cent last year. But management has reiterated its aim to improve this to between 60 and 65 per cent, particularly as demands on working capital normalise next year. The business still needs work, but now that a lot of the ugliness has made its way through the financial statements, we see the continued share sell-off as unjustified. Buy.' | mfhmfh | |
28/11/2018 11:00 | good to see a direct buy today. These are the recent director buys: 08.08.18: CFO - 20,000 shares at £7.40 (£148,000) 19.09.18: Chairman - 14,000 shares at £6.31 (£88,340) 20.09.18: CEO - 35,000 shares at £6.60 (£231,000) 28.09.18: PDMR - 70,000 shares at £6.86 (£480,200) | mfhmfh | |
28/11/2018 10:11 | nope - top of channel here. Times write up caused the jump - volume low. chart is broken - this is going down to £3 | hyper ai | |
28/11/2018 10:06 | Nice £35k splash by a director more to come me thinks | tsmith2 | |
28/11/2018 09:52 | Sharp bounce to £7 on chart | tsmith2 | |
28/11/2018 09:47 | looks a short here | hyper ai | |
27/11/2018 19:18 | Subs required | tsmith2 | |
27/11/2018 18:36 | Do you have a link the article or can paste article? | tsmith2 | |
27/11/2018 17:56 | buy rating reiterated in today's IC. | mfhmfh | |
27/11/2018 15:23 | Could be a v interesting last hour | tsmith2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions